Insider Trading29 Jun 2026, 10:15 am
Indo Us Bio-Tech Closes Trading Window for Q2 FY27
AI Summary
Indo Us Bio-Tech Ltd has announced the closure of its trading window for designated persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for designated persons.
- Effective until 48 hours post Q2 FY27 results.
- Aims to prevent insider trading.
- Complies with SEBI regulations.
Price Impact
More from INDOUS